Sign in
RPTX Stock Price, Chart, Stats & News
Repare Therapeutics Inc.
Save
Repare Therapeutics Inc. (RPTX) does not currently pay a dividend.
114.24M
Market cap
–
Current P/E
–
Forward P/E
RPTX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 22.98% |
Operating margin | -632.62% |
Pretax margin | -599.51% |
Net margin | -608.26% |
Effective tax rate | -1.46% |
ROA | -56.96% |
ROE | -57.56% |
D/E | 0.00x |
Interest coverage ratio | – |
RPTX valuation
P/E | – |
P/S | 9.62x |
P/B | 0.99x |
P/CF | -1.62x |
P/FCF | -1.63x |
P/OCF | -1.62x |
PEG | -0.05x |
EV multiple | -2.46x |
About
Repare Therapeutics Inc. is a precision oncology biopharmaceutical company in the clinical stage, focused on discovering and developing innovative therapies. Operating across Canada and the United States, the company leverages a synthetic lethality approach to identify new treatments. Central to their efforts is the proprietary, genome-wide, and CRISPR-enabled SNIPRx platform, which systematically uncovers and advances highly targeted cancer medicines.
Similar securities
Based on sector and market capitalization
Report issue